Table 6.
The source of the peptides | Protein fragment | observed m/z | calculated m/z | Amino acid sequences | Peptide having antioxidant activity |
---|---|---|---|---|---|
bottom phase | β-Lg 27–32 | 670.74 | 672.7795 | DIQKVA | |
hydrolysate | β-Lg 153–159 | 758.531 | 757.9285 | DKALKAL | |
top phase | β-Lg 173–178 | 758.558 | 757.8163 | EEQCHI | |
hydrolysate | β-Lg 56–61 | 791.634 | 793.875 | RVYVEE | |
top phase | β-Lg 144–150 | 791.638 | 789.7943 | VDDEALE | |
top phase | β-Lg 27–38 | 1381.72 | 1380.5633 | DIQKVAGTWYSL | WY |
WYS | |||||
hydrolysate | β-Lg 22–35 | 1545.457 | 1547.8328 | TMKGLDIQKVAGTW | |
top phase | β-Lg 82–96 | 1641.930 | 1642.0331 | CAQKKIIAEKTKIPA | |
hydrolysate | β-Lg 104–118 | 1844.441 | 1842.079 | NENKVLVLDTDYKKY | VLVLDTDYK |
top phase | 1845.058 | ||||
hydrolysate | β-Lg 82–98 | 1884.995 | 1888.3423 | CAQKKIIAEKTKIPAVF | KTKIPAVF |
top phase | 1885.041 | IPAVF | |||
hydrolysate | β-Lg 18–35 | 1989.167 | 1989.3606 | IVTQTMKGLDIQKVAGTW | |
top phase | 1989.012 | ||||
bottom phase | β-Lg 42–50 | 903.708 | 903.9847 | ASDISLLDA | KTKIPAVF |
β-Lg 91–98 | 903.1327 | KTKIPAVF | IPAVF | ||
bottom phase | β-Lg 78–90 | 1433.787 | 1432.6116 | ENGECAQKKIIAE | |
bottom phase | α-La 45–58 | 1647.948 | 1646.7708 | WVCTTFHTSGYDTQ | |
β-Lg 134–148 | 1648.8233 | ACQCLVRTPEVDDEA | |||
hydrolysate | α-La32–50 | 2102.247 | 2101.4244 | KDLKGYGGVSLPEWVCTTF | |
bottom phase | β-Lg17–35 | 2102.569 | 2102.5200 | LIVTQTMKGLDIQKVAGTW | |
bottom phase | α-La 45–62 | 2061.068 | 2058.2723 | WVCTTFHTSGYDTQAIVQ | |
bottom phase | β-Lg 84–102 | 2139.356 | 2141.6256 | QKKIIAEKTKIPAVFKIDA | KTKIPAVF |
β-Lg 91–109 | 2141.5822 | KTKIPAVFKIDALNENKVL | IPAVF | ||
bottom phase | α-La51–69 | 2247.202 | 2144.1719 | HTSGYDTQAIVQNNDSTEY | |
hydrolysate | β-Lg 49–58 | 1119.585 | 1119.2426 | DAQSAPLRVY | YVEEL43 |
β-Lg 43–53 | 1119.1936 | SDISLLDAQSA | |||
hydrolysate | β-Lg 48–58 | 1232.665 | 1232.402 | LDAQSAPLRVY | |
α-La 70–79 | 1233.455 | GLFQINNKIW | |||
hydrolysate | α-La116–128 | 1514.768 | 1515.7545 | DKVGINYWLAHKA |